Sanofi SA logo

Sanofi SA

€ 87.54 (+0.62%) Nov 25
On watch
P/E:
16.55
P/B:
1.54
Market Cap:
€ 110.96B ($ 115.55B)
Enterprise V:
€ 125.29B ($ 130.49B)
Volume:
1.26M
Avg Vol (2M):
1.83M
Also Trade In:
Volume:
1.26M
Market Cap €:
110.96B
Market Cap $:
115.55B
PE Ratio:
16.55
Avg Vol (2-Month):
1.83M
Enterprise Value €:
125.29B
Enterprise Value $:
130.49B
PB Ratio:
1.54
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Financials (Next Earnings Date:2023-02-03 Est.)

XPAR:SAN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 42,039
EPS (TTM) (€) 5.29
Beta 0.56
Volatility % 24.53
14-Day RSI 61.77
14-Day ATR (€) 1.589094
20-Day SMA (€) 86.233
12-1 Month Momentum % -4.51
52-Week Range (€) 76.45 - 106.080482
Shares Outstanding (Mil) 1,267.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sanofi SA Filings

Document Form Filing Date
No Filing Data

Sanofi SA Analysis

Share your research